Skip to main content
Merck & Co.

Merck & Co.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).www.merck.com

Search complete. 1150 mentions across 626 episodes found for "Merck & Co.".

Oct 26, 2026

Bill GundersonHOST
21:25
Then Friday is also a very important day with Amazon.
Bill GundersonHOST
21:31
Intel reporting, Altria, Starbucks, Merck, Lilly, Bristol Myers, MasterCard, Chenier Energy.
Bill GundersonHOST
21:43
Very important day on Thursday.
Bill GundersonHOST
21:46
And then on Friday, we're going to get ExxonMobil reporting.
Bill GundersonHOST
25:29
He makes an interesting comment.
Bill GundersonHOST
25:32
He says it's more important not what AI does for the Mag 7, but for the other companies.
Bill GundersonHOST
25:41
493 S&P 500 companies right is it going to help Merck is it going to help Chevron is it going to help Ford is it going to help the rest of us out there will we gain benefits will revenue growth go up will productivity go up he says that so far it's it's delivered a zero payoff outside of tech i was talking to a guy on the trip with the new york giants he works for service now i told him wow that's one of the best stocks i ever found but now it has really really flattened off in recent years it's gone pretty good right now but not like it was in the early days And I asked him what they're doing in that AI space.
Bill GundersonHOST
26:31
And it's actually quite interesting.
Bill GundersonHOST
21:25
Then Friday is also a very important day with Amazon.
Bill GundersonHOST
21:31
Intel reporting, Altria, Starbucks, Merck, Lilly, Bristol Myers, MasterCard, Chenier Energy.
Bill GundersonHOST
21:43
Very important day on Thursday.
Bill GundersonHOST
21:46
And then on Friday, we're going to get ExxonMobil reporting.
Bill GundersonHOST
25:29
He makes an interesting comment.
Bill GundersonHOST
25:32
He says it's more important not what AI does for the Mag 7, but for the other companies.
Bill GundersonHOST
25:41
493 S&P 500 companies right is it going to help Merck is it going to help Chevron is it going to help Ford is it going to help the rest of us out there will we gain benefits will revenue growth go up will productivity go up he says that so far it's it's delivered a zero payoff outside of tech i was talking to a guy on the trip with the new york giants he works for service now i told him wow that's one of the best stocks i ever found but now it has really really flattened off in recent years it's gone pretty good right now but not like it was in the early days And I asked him what they're doing in that AI space.
Bill GundersonHOST
26:31
And it's actually quite interesting.
Matt PiperCORRESPONDENT
18:51
He sued in December over the broadcaster's misleading edit of a speech he gave to supporters shortly before the January 6th assault on the Capitol.
Matt PiperCORRESPONDENT
18:59
Shares of Moderna and Merck are falling after reports about the results of the company's widely anticipated personalized melanoma vaccine, suggesting a possible leak of the data that's slated to be released this weekend.
Matt PiperCORRESPONDENT
19:11
Shares of Moderna plunged as much as 25 percent, while Merck shares dropped 4 percent.
Matt PiperCORRESPONDENT
19:17
Elsewhere on Wall Street, everything is down.
Matt PiperCORRESPONDENT
19:19
Matt Piper, Bloomberg Radio.
speaker_4NARRATOR
32:21
Thrivent Large Cap Value Fund's top 10 holdings as of 31 August 2026, excluding derivatives and cash, together accounted for 27.59% of the fund.
speaker_4NARRATOR
32:32
They are Microsoft Corp., 3.82%, Exxon Mobile Holdings Corp., 3.04%, Amazon.com, Inc., 2.98%, Samsung Electronics Co., Ltd., 2.95%, Bank of America Corp., 2.65%, Merck & Co., Inc., 2.62%, Wells Fargo & Co., 2.56%, Cisco CIST, Inc., 2.52%, Alphabet, Inc., Class C, 2.36%, and Johnson & Johnson, 2.09%.
speaker_4NARRATOR
33:10
Thrivent MidCap Value ETF's top 10 holdings as of the 31st of August, 2026, excluding derivatives and cash, together accounted for 19.6% of the fund.
speaker_4NARRATOR
33:18
They are M&T Bancorp, 2.17%, Intercontinental X King, 2.15%, U.S. Bancorp, 2.08%.
Steve BokorHOST
1:46
And 15 of the Dow 30 stocks are higher, led by Cisco up 3.5, plus Goldman Sachs and NVIDIA.
Steve BokorHOST
1:52
Dogs would be Merck and Disney.
Steve BokorHOST
1:54
Turning to Canada, the TSX up 243 points, 36,031.
Steve BokorHOST
2:00
We're getting a lift in the mining and gold stocks, no doubt due in part to the election results in British Columbia.
Nick EdeHOST
1:03
The earnings list is long.
Nick EdeHOST
1:05
Tech giants Alphabet, Amazon.com, and Microsoft are on deck, along with Visa, Coca-Cola, Boeing, SK Hynix, Eli Lilly, MasterCard, Intel, Merck, Caterpillar, Anheuser-Busch, ExxonMobil, Chevron, AbbVie, AstraZeneca, and Colgate Palmolive.
Nick EdeHOST
1:22
We are still early in the season, with only 24% of S&P 500 companies reported as of Friday.
Nick EdeHOST
1:28
Earnings so far are up a big 31% from last quarter, with financial companies the most heavily represented sector.
Mack PaulGUEST
14:02
He could see some of these companies starting to locate near universities.
Mack PaulGUEST
14:06
Merck went to Charlottesville and Virginia.
Mack PaulGUEST
14:08
So that had an impact on him.
Mack PaulGUEST
14:11
And he got out a map and looked at North Carolina.
Jen UrsulaHOST
1:19
Two drug companies say their new cancer treatment cuts the risk of death of melanoma by 42%.
Mark MayfieldCORRESPONDENT
1:26
Merck and Moderna said on Thursday that a new large trial shows their cancer vaccine called Intesmoron autogene reduces the risk of melanoma death when combined with Merck's immunotherapy medicine, Keytruda.
Mark MayfieldCORRESPONDENT
1:39
The trial of over 1,000 patients also showed the treatment reduced the spread of the cancer by 38%.
Mark MayfieldCORRESPONDENT
1:45
Moderna's CEO says the treatment works by creating new T-cells that are specific to your tumor.
Josh BertacciniHOST
51:58
You know, I remember as a kid being raised by a single mom, my mom, a lot of the time when she would go on business trips, right.
Josh BertacciniHOST
52:03
She's working in the pharmaceutical industry, Merck, uh, Novartis, those kinds of companies, a couple of different ones.
Josh BertacciniHOST
52:09
But say she was like going on a trip to, well, I mean, we live near New York.
Josh BertacciniHOST
52:12
She's going to the city, right? Or she's going to Philly.
Pete DominickHOST
12:36
Speaking of good news, reducing the risk of death or recurrence of melanoma by almost half.
Pete DominickHOST
12:41
An encouraging signal for treatment seeking federal approval that boosted the fortunes of drug makers Moderna and Merck that usher in a new wave of cancer treatments.
Pete DominickHOST
12:50
RNA is a miracle.
Pete DominickHOST
12:52
A miracle.

616 more episodes mention Merck & Co..

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.